Insider · CIK 0001226385

LEFKOWITZ ROBERT J MD

Reports to the SEC for 1 company · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001226385

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-13	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+44.9K sh	—	—	44,906
2024-05-13	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+36.8K sh	—	—	36,810
2024-04-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+8,032 sh	—	—	48,364
2024-04-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,032 sh	—	—	0
2023-05-21	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,302 sh	—	—	40,332
2023-05-21	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,302 sh	—	—	0
2023-04-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+8,032 sh	—	—	8,032
2023-04-28	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+12.7K sh	—	—	12,658
2022-05-21	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14.4K sh	—	—	14,402
2022-05-21	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+9,302 sh	—	—	9,302
2022-04-30	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,024 sh	—	—	31,030
2022-04-30	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,024 sh	—	—	0
2021-04-30	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,024 sh	—	—	4,024
2021-04-30	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,475 sh	—	—	6,475
2021-04-24	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10.6K sh	—	—	27,006
2021-04-24	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−10.6K sh	—	—	0
2020-04-26	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,466 sh	—	—	16,368
2020-04-26	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,466 sh	—	—	0
2020-04-24	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,115
2020-04-24	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+10.6K sh	—	—	10,638
2019-04-26	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,519 sh	—	—	6,519
2019-04-26	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,466 sh	—	—	3,466
2018-04-27	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director	AAward	+2,564 sh	—	—	12,902
2018-04-27	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,857 sh	—	—	2,857
2017-04-28	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director	AAward	+1,281 sh	—	—	10,338
2017-04-28	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,857 sh	—	—	2,857
2016-04-29	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director	AAward	+1,432 sh	—	—	9,057
2016-04-29	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,857 sh	—	—	2,857
2015-04-24	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director	AAward	+18.7K sh	—	—	53,376
2015-04-24	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-05-10	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director	AAward	+10.1K sh	—	—	21,865
2013-05-10	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2012-04-27	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director	AAward	+11.8K sh	—	—	11,764
2012-04-27	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-04-29	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2010-04-30	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2009-04-24	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2004-05-20	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000

Recent filings

Accepted (ET)
May 134
LEFKOWITZ ROBERT J MD0001127602-24-015080
SEC(opens sec.gov)
Apr 294
LEFKOWITZ ROBERT J MD0001127602-24-013556
SEC(opens sec.gov)
May 224
LEFKOWITZ ROBERT J MD0001127602-23-016433
SEC(opens sec.gov)
Apr 284
LEFKOWITZ ROBERT J MD0001127602-23-013784
SEC(opens sec.gov)
May 234
LEFKOWITZ ROBERT J MD0001127602-22-015370
SEC(opens sec.gov)
May 24
LEFKOWITZ ROBERT J MD0001127602-22-012829
SEC(opens sec.gov)
May 34
LEFKOWITZ ROBERT J MD0001127602-21-014967
SEC(opens sec.gov)
Apr 274
LEFKOWITZ ROBERT J MD0001127602-21-014520
SEC(opens sec.gov)
Apr 274
LEFKOWITZ ROBERT J MD0001127602-20-014565
SEC(opens sec.gov)

Companies

LEXICON PHARMACEUTICALS, INC.DirectorLXRX

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 773811160